Tomorrow (July 15, 2026) the landmark administrative hearing on US cannabis rescheduling will come to a close. Today (July 14),
This week, what is perhaps the most consequential hearing in the history of the US, and indeed the global cannabis
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have
Trulieve’s uplisting to the NYSE, the first of its kind in US history, has undoubtedly caught the attention of every
The US Department of Justice has filed a federal lawsuit seeking $8.3m plus interest from New Jersey-based cannabis multistate operator
According to recent analysis from the Congressional Research Service, cannabis businesses may not need to wait for rescheduling to challenge
As the excitement around President Donald Trump’s executive order to push forward with cannabis rescheduling has faded, the bill is
The United States is intensifying its controversial overseas ‘war on drugs’ even as a prolonged government shutdown paralyses domestic policy,
There is a frustrating misimpression circulating in the cannabis community regarding rescheduling. Many headlines state that Trump is considering finishing
Pressure is building on the Trump administration from parties on both sides of the aisle to take a definitive stance
Cannabis stocks across North America have skyrocketed to their highest point so far this year, despite a lukewarm promise from
The cannabis industry is once again awash with hope and speculation over the promise of rescheduling following reports that President Trump has promised the industry that ‘it’s something we’re going to look at’.
Terrance Cole, has been confirmed as the new permanent head of the Drug Enforcement Administration (DEA), and will now be responsible for the future of the landmark cannabis rescheduling project.
As more details of the Trump administration’s fiscal plans for the year ahead come to light, so do more thinly veiled attacks on cannabis, this time the ongoing cannabis rescheduling process.
Cannabis rescheduling was thrown back into the spotlight last week as the new potential head of the Drug Enforcement Administration (DEA) said it would be a ‘priority’.
A coalition of pro-cannabis medical professionals has dropped its lawsuit against the Drug Enforcement Administration (DEA), clearing one of the many hurdles preventing the process from progressing.
The US Cannabis Roundtable (USCR), one of the most influential advocacy groups in the country, is ‘still optimistic about the President acting on cannabis reform’.
Controversial former congressman and Trump loyalist Matt Gaetz sent cannabis stocks rallying last week after suggesting in an op-ed that
We won’t spam you
